%PDF-1.6
%
1 0 obj
<>]/Pages 2 0 R/Type/Catalog>>
endobj
435 0 obj
<>stream
Adobe Acrobat 9.55 Paper Capture Plug-in
2013-12-11T14:42:47-05:00
2014-01-31T18:12:18-05:00
ScandAll PRO V1.8 Update1
2014-01-31T18:12:18-05:00
uuid:4a79c9f6-558e-4109-a16d-0699fc29ea55
uuid:10d7c520-6fa1-4fff-b737-f31a34a149d2
application/pdf
1
B
http://ns.adobe.com/pdf/1.3/
pdf
Adobe PDF Schema
internal
A name object indicating whether the document has been modified to include trapping information
Trapped
Text
http://ns.adobe.com/xap/1.0/mm/
xmpMM
XMP Media Management Schema
internal
UUID based identifier for specific incarnation of a document
InstanceID
URI
http://www.aiim.org/pdfa/ns/id/
pdfaid
PDF/A ID Schema
internal
Part of PDF/A standard
part
Integer
internal
Amendment of PDF/A standard
amd
Text
internal
Conformance level of PDF/A standard
conformance
Text
endstream
endobj
2465 0 obj
<>
endobj
2 0 obj
<>
endobj
172 0 obj
<>
endobj
171 0 obj
<>
endobj
253 0 obj
<>
endobj
334 0 obj
<>
endobj
415 0 obj
<>
endobj
347 0 obj
<>
endobj
363 0 obj
<>
endobj
379 0 obj
<>
endobj
395 0 obj
<>
endobj
411 0 obj
<>
endobj
428 0 obj
<>
endobj
408 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Type/Page>>
endobj
412 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
416 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
419 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
422 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
425 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
429 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Type/Page>>
endobj
432 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
2474 0 obj
<>stream
BT
/CS0 cs 0.169 0.161 0.165 scn
/T1_0 1 Tf
-0.035 Tc 3 Tr 11.8358 0 0 12.2 523.27 742.33 Tm
(120 )Tj
12.0479 0 0 12.2 112.19 706.33 Tm
(78. )Tj
-0.008 Tc 12.2 0 0 12.2 140.75 706.33 Tm
(Christ)Tj
0.29 0.286 0.29 scn
0 Tc 2.415 0 Td
(, )Tj
0.169 0.161 0.165 scn
-0.035 Tc 11.7795 0 0 12.2 175.87 706.33 Tm
(F. )Tj
-0.0176 Tc 12.2 0 0 12.2 188.99 706.33 Tm
(and )Tj
-0.035 Tc 11.5165 0 0 12.2 209.24 706.33 Tm
(Z. )Tj
-0.0088 Tc 12.2 0 0 12.2 222.42 706.33 Tm
(Debyser, )Tj
0.0284 Tc 3.812 0 Td
(The )Tj
0.0212 Tc 1.892 0 Td
(LEDGF/p75 )Tj
0.0235 Tc 5.466 0 Td
(integrase )Tj
0.0269 Tc 4.072 0 Td
(interaction, )Tj
0 Tc 5.112 0 Td
(a )Tj
-0.0132 Tc 0.757 0 Td
(novel )Tj
0.0416 Tc 2.439 0 Td
(target )Tj
0.0271 Tc -30.265 -1.121 Td
(for )Tj
0.0259 Tc 1.535 0 Td
(anti-HIV )Tj
0.0228 Tc 4.041 0 Td
(therapy. )Tj
/T1_1 1 Tf
-0.0051 Tc 11.8 0 0 11.8 255.4 692.65 Tm
(Virology, )Tj
/T1_0 1 Tf
0.0089 Tc 12.2 0 0 12.2 303.05 692.65 Tm
(2013.435\(1\): )Tj
-0.035 Tc 11.8981 0 0 12.2 371.06 692.65 Tm
(p. )Tj
-0.0302 Tc 12.2 0 0 12.2 384.06 692.65 Tm
(102-9. )Tj
-0.035 Tc 11.8402 0 0 12.2 112.19 659.29 Tm
(79. )Tj
-0.0183 Tc 12.2 0 0 12.2 140.66 659.29 Tm
(Sakuma, )Tj
0.0076 Tc 11.4 0 0 11.4 187.39 659.29 Tm
(R., )Tj
-0.035 Tc 11.4061 0 0 12.2 206.91 659.29 Tm
(S. )Tj
-0.0171 Tc 12.2 0 0 12.2 221.88 659.29 Tm
(Ohmine, )Tj
-0.0078 Tc 3.855 0 Td
(and )Tj
-0.035 Tc 11.3589 0 0 11.4 291.81 659.29 Tm
(Y. )Tj
-0.0148 Tc 12.2 0 0 12.2 308.79 659.29 Tm
(Ikeda, )Tj
0.0292 Tc 2.875 0 Td
(Determinants )Tj
0.0172 Tc 6.17 0 Td
(for )Tj
0.0305 Tc 1.701 0 Td
(the )Tj
0.0204 Tc 1.771 0 Td
(rhesus )Tj
0.01 Tc 3.147 0 Td
(monkey )Tj
0.0312 Tc -29.456 -1.142 Td
(TRIM5alpha-mediated )Tj
0.0228 Tc 10.298 0 Td
(block )Tj
0.05 Tc 12.5203 0 0 12.2 300.84 645.36 Tm
(of )Tj
0.0404 Tc 12.2 0 0 12.2 317.49 645.36 Tm
(the )Tj
0.0169 Tc 1.863 0 Td
(late )Tj
0.0286 Tc 2.056 0 Td
(phase )Tj
0.05 Tc 12.5203 0 0 12.2 401.16 645.36 Tm
(of )Tj
0.0417 Tc 12.2 0 0 12.2 418.02 645.36 Tm
(HIV )Tj
-0.035 Tc 11.4729 0 0 12.2 440.75 645.36 Tm
(-1 )Tj
0.0094 Tc 12.2 0 0 12.2 457.66 645.36 Tm
(replication. )Tj
/T1_1 1 Tf
-0.0308 Tc 11.8 0 0 11.8 522.48 645.36 Tm
(The )Tj
0.0176 Tc -32.43 -1.179 Td
(Journal )Tj
0.0344 Tc 3.479 0 Td
(ofbiological )Tj
0.227 0.223 0.227 scn
0.0078 Tc 5.411 0 Td
(chemistry, )Tj
/T1_0 1 Tf
0.0089 Tc 12.2 0 0 12.2 297.77 631.45 Tm
(2010.285\(6\): )Tj
0.169 0.161 0.165 scn
-0.035 Tc 11.5582 0 0 12.2 366.02 631.45 Tm
(p. )Tj
-0.0176 Tc 12.2 0 0 12.2 378.34 631.45 Tm
(3784-93. )Tj
-0.035 Tc 11.7391 0 0 12.2 112.35 598.09 Tm
(80. )Tj
-0.0106 Tc 12.2 0 0 12.2 140.36 598.09 Tm
(Zhang)Tj
0.29 0.286 0.29 scn
0 Tc 2.545 0 Td
(, )Tj
0.227 0.223 0.227 scn
/T1_2 1 Tf
-0.035 Tc 14.4564 0 0 16.1 182.85 598.09 Tm
(x., )Tj
0.169 0.161 0.165 scn
/T1_0 1 Tf
-0.0117 Tc 12.2 0 0 12.2 206.51 598.09 Tm
(et )Tj
-0.0227 Tc 1.436 0 Td
(al., )Tj
0.0384 Tc 1.911 0 Td
(Inhibitory )Tj
0.0059 Tc 5.072 0 Td
(effect )Tj
0.05 Tc 12.2421 0 0 12.2 346.2 598.09 Tm
(of )Tj
0.0439 Tc 12.2 0 0 12.2 365.02 598.09 Tm
(human )Tj
0.0404 Tc 3.652 0 Td
(TRIM5alpha )Tj
0.004 Tc 6.275 0 Td
(on )Tj
0.0454 Tc 1.756 0 Td
(HIV-l )Tj
0.0336 Tc -30.111 -1.142 Td
(production)Tj
0.369 0.372 0.372 scn
0 Tc 4.66 0 Td
(. )Tj
0.169 0.161 0.165 scn
/T1_1 1 Tf
-0.0014 Tc 11.8 0 0 11.8 203.16 584.16 Tm
(Microbes )Tj
0.0476 Tc 4.092 0 Td
(and )Tj
0.0027 Tc 1.804 0 Td
(infection)Tj
0.29 0.286 0.29 scn
0 Tc 3.521 0 Td
(/)Tj
0.169 0.161 0.165 scn
0.0125 Tc 0.285 0 Td
[(Institut )47(Pasteur)]TJ
0.29 0.286 0.29 scn
0 Tc 6.359 0 Td
(, )Tj
0.227 0.223 0.227 scn
/T1_0 1 Tf
-0.0217 Tc 12.2 0 0 12.2 398.33 584.16 Tm
(2010. )Tj
0.169 0.161 0.165 scn
-0.0196 Tc 2.489 0 Td
(12\(10\): )Tj
-0.035 Tc 11.8981 0 0 12.2 466.58 584.16 Tm
(p. )Tj
-0.0227 Tc 12.2 0 0 12.2 478.91 584.16 Tm
(768-77)Tj
0.29 0.286 0.29 scn
0 Tc 2.784 0 Td
(. )Tj
0.169 0.161 0.165 scn
-0.035 Tc 9.8831 0 0 12.2 112.15 550.8 Tm
(81.. )Tj
-0.0067 Tc 12.2 0 0 12.2 140.1 550.8 Tm
(Battivelli, )Tj
0.0093 Tc 11.4 0 0 11.4 191.21 550.8 Tm
(E., )Tj
-0.0314 Tc 12.2 0 0 12.2 207.95 550.8 Tm
(et )Tj
-0.0227 Tc 0.964 0 Td
(al., )Tj
0.0308 Tc 1.496 0 Td
(Gag )Tj
0.0051 Tc 2.007 0 Td
(cytotoxic )Tj
0 Tc 4.053 0 Td
(T )Tj
0.0131 Tc 0.925 0 Td
(lymphocyte )Tj
0.0147 Tc 5.112 0 Td
(escape )Tj
0.0294 Tc (mutations )Tj
0.0252 Tc 7.496 0 Td
(can )Tj
0.0184 Tc 1.713 0 Td
(increase )Tj
0.0109 Tc -29.317 -1.14 Td
(sensitivity )Tj
0.05 Tc 12.2421 0 0 12.2 196.68 536.89 Tm
(of )Tj
12.2989 0 0 12.2 211.62 536.89 Tm
(HIV-l )Tj
0.0122 Tc 12.2 0 0 12.2 249.33 536.89 Tm
(to )Tj
0.0488 Tc 1.26 0 Td
(human )Tj
0.033 Tc 3.376 0 Td
(TRIM5alpha, )Tj
0.0192 Tc 6.198 0 Td
(linking )Tj
0.0281 Tc 3.364 0 Td
(intrinsic )Tj
0.05 Tc 12.2198 0 0 12.2 470.51 536.89 Tm
(and )Tj
0.0274 Tc 12.2 0 0 12.2 494.99 536.89 Tm
(acquired )Tj
0.663 0.678 0.674 scn
0 Tc 4.091 0 Td
(' )Tj
0.169 0.161 0.165 scn
0.0138 Tc -33.184 -1.141 Td
(immunity. )Tj
/T1_1 1 Tf
0.0142 Tc 11.8 0 0 11.8 195.73 522.97 Tm
(Journal )Tj
0.0387 Tc 3.458 0 Td
(ofvirology)Tj
0.29 0.286 0.29 scn
0 Tc 4.486 0 Td
(, )Tj
0.227 0.223 0.227 scn
/T1_0 1 Tf
0.0089 Tc 12.2 0 0 12.2 295.13 522.97 Tm
(2011.85\(22\): )Tj
0.169 0.161 0.165 scn
0 Tc 5.575 0 Td
(p)Tj
0.29 0.286 0.29 scn
0.548 0 Td
(. )Tj
0.169 0.161 0.165 scn
-0.0195 Tc 0.537 0 Td
(11846-54. )Tj
-0.035 Tc 11.9487 0 0 12.2 111.87 489.61 Tm
(82. )Tj
-0.0064 Tc 12.2 0 0 12.2 140.04 489.61 Tm
(Overbaugh)Tj
0.29 0.286 0.29 scn
0 Tc 4.401 0 Td
(, )Tj
0.169 0.161 0.165 scn
11.4 0 0 11.4 202.49 489.61 Tm
(J)Tj
0.29 0.286 0.29 scn
0.448 0 Td
(. )Tj
0.169 0.161 0.165 scn
-0.0078 Tc 12.2 0 0 12.2 216.11 489.61 Tm
(and )Tj
/T1_2 1 Tf
0.0419 Tc 11.4 0 0 11.4 239.27 489.61 Tm
(L. )Tj
/T1_0 1 Tf
-0.0109 Tc 12.2 0 0 12.2 256.02 489.61 Tm
(Morris)Tj
0.29 0.286 0.29 scn
0 Tc 2.704 0 Td
(, )Tj
0.169 0.161 0.165 scn
0.0284 Tc 0.754 0 Td
(The )Tj
0.0235 Tc 2.112 0 Td
(Antibody )Tj
0.0152 Tc 4.423 0 Td
(Response )Tj
0.0254 Tc 4.48 0 Td
(against )Tj
0.05 Tc 12.2057 0 0 12.2 475.14 489.61 Tm
(HIV-l)Tj
0.29 0.286 0.29 scn
0 Tc 12.2 0 0 12.2 507.59 489.61 Tm
(. )Tj
0.227 0.223 0.227 scn
/T1_1 1 Tf
0.0063 Tc 11.8 0 0 11.8 516.97 489.61 Tm
(Cold )Tj
0.169 0.161 0.165 scn
0.0139 Tc -31.955 -1.181 Td
(Spring )Tj
0.0115 Tc 2.959 0 Td
(Harbor )Tj
0.0149 Tc 3.239 0 Td
(perspectives )Tj
0.227 0.223 0.227 scn
-0.0278 Tc 5.404 0 Td
(in )Tj
0.169 0.161 0.165 scn
0.0134 Tc 1.025 0 Td
(medicine)Tj
0.29 0.286 0.29 scn
0 Tc 3.731 0 Td
(, )Tj
0.227 0.223 0.227 scn
/T1_0 1 Tf
0.0105 Tc 12.2 0 0 12.2 338.57 475.68 Tm
(2012.2\(1\): )Tj
0.169 0.161 0.165 scn
-0.035 Tc 11.8981 0 0 12.2 394.34 475.68 Tm
(p. )Tj
0.227 0.223 0.227 scn
-0.0173 Tc 12.2 0 0 12.2 406.91 475.68 Tm
(a007039. )Tj
0.169 0.161 0.165 scn
-0.035 Tc 11.7391 0 0 12.2 111.87 442.57 Tm
(83. )Tj
-0.0163 Tc 12.2 0 0 12.2 140.03 442.57 Tm
(Chung, )Tj
0 Tc 3.294 0 Td
(A)Tj
0.29 0.286 0.29 scn
0.768 0 Td
(.)Tj
0.169 0.161 0.165 scn
-0.035 Tc 12.1201 0 0 12.2 192.2 442.57 Tm
(W., )Tj
-0.0117 Tc 12.2 0 0 12.2 214.91 442.57 Tm
(et )Tj
-0.0227 Tc 1.141 0 Td
(al., )Tj
0.0451 Tc 1.636 0 Td
(Immune )Tj
0.0108 Tc 4.03 0 Td
(escape )Tj
0.0213 Tc 3.166 0 Td
(from )Tj
0.0062 Tc 2.505 0 Td
(HIV-specific )Tj
0.0245 Tc 5.758 0 Td
(antibody-dependent )Tj
0.0249 Tc -24.373 -1.161 Td
(cellular )Tj
0.008 Tc 3.462 0 Td
(cytotoxicity )Tj
0.0039 Tc 5.171 0 Td
(\(ADCC\) )Tj
0.0427 Tc 3.791 0 Td
(pressure)Tj
0.29 0.286 0.29 scn
0 Tc 3.617 0 Td
(. )Tj
0.169 0.161 0.165 scn
/T1_1 1 Tf
0.008 Tc 11.8 0 0 11.8 342.09 428.4 Tm
(Proceedings )Tj
0.05 Tc 14.2769 0 0 11.8 405.96 428.4 Tm
(of )Tj
0.227 0.223 0.227 scn
0.0032 Tc 11.8 0 0 11.8 419.14 428.4 Tm
(the )Tj
0.169 0.161 0.165 scn
0.0124 Tc 1.525 0 Td
(National )Tj
0.227 0.223 0.227 scn
0.0144 Tc 3.851 0 Td
(Academy )Tj
0.169 0.161 0.165 scn
0.05 Tc 13.9795 0 0 11.8 530.28 428.4 Tm
(of )Tj
0.01 Tc 11.8 0 0 11.8 139.66 414.73 Tm
(Sciences )Tj
0.05 Tc 14.2769 0 0 11.8 184.2 414.73 Tm
(of )Tj
-0.0069 Tc 11.8 0 0 11.8 196.9 414.73 Tm
(the )Tj
0.0102 Tc 1.526 0 Td
(United )Tj
0.0048 Tc 2.958 0 Td
(States )Tj
0.05 Tc 14.2769 0 0 11.8 281.88 414.73 Tm
(of )Tj
0.227 0.223 0.227 scn
0.0162 Tc 11.8 0 0 11.8 293.7 414.73 Tm
(America, )Tj
/T1_0 1 Tf
-0.0266 Tc 12.2 0 0 12.2 341.21 414.73 Tm
(2011. )Tj
0.169 0.161 0.165 scn
-0.0141 Tc 2.47 0 Td
(108\(18\))Tj
0.29 0.286 0.29 scn
0 Tc 3.137 0 Td
(: )Tj
0.169 0.161 0.165 scn
-0.035 Tc 11.8981 0 0 12.2 415.22 414.73 Tm
(p. )Tj
-0.0165 Tc 12.2 0 0 12.2 427.55 414.73 Tm
(7505-10. )Tj
-0.035 Tc 11.7391 0 0 12.2 111.87 381.36 Tm
(84. )Tj
-0.013 Tc 12.2 0 0 12.2 139.65 381.36 Tm
(Voit, )Tj
0.0187 Tc 11.4 0 0 11.4 169.39 381.36 Tm
(R.A., )Tj
0.0079 Tc 12.2 0 0 12.2 200.51 381.36 Tm
(et )Tj
-0.035 Tc 11.6093 0 0 12.2 214.68 381.36 Tm
(al.)Tj
0.29 0.286 0.29 scn
0 Tc 12.2 0 0 12.2 226.37 381.36 Tm
(, )Tj
0.169 0.161 0.165 scn
0.0332 Tc 0.675 0 Td
(Generation )Tj
0.05 Tc 12.2421 0 0 12.2 298.2 381.36 Tm
(of )Tj
12.2207 0 0 12.2 313.55 381.36 Tm
(an )Tj
0.0417 Tc 12.2 0 0 12.2 331.38 381.36 Tm
(HIV )Tj
0.0271 Tc 2.282 0 Td
(Resistant )Tj
0.0067 Tc 4.324 0 Td
(T-cell )Tj
0.0236 Tc 2.856 0 Td
(Line )Tj
0.0326 Tc 2.348 0 Td
(by )Tj
0.0321 Tc 1.466 0 Td
(Targeted )Tj
0.0367 Tc -28.929 -1.16 Td
("Stacking" )Tj
0.05 Tc 12.2421 0 0 12.2 205.56 367.21 Tm
(of )Tj
0.0243 Tc 12.2 0 0 12.2 223.14 367.21 Tm
(Restriction )Tj
0.0187 Tc 5.293 0 Td
(Factors. )Tj
/T1_1 1 Tf
0.0062 Tc 11.8 0 0 11.8 337.08 367.21 Tm
(Molecular )Tj
0.227 0.223 0.227 scn
0.0042 Tc 4.9 0 Td
(therapy)Tj
0.369 0.372 0.372 scn
0 Tc 3.126 0 Td
(: )Tj
0.227 0.223 0.227 scn
-0.0069 Tc 0.982 0 Td
(the )Tj
0.169 0.161 0.165 scn
0.0331 Tc 1.731 0 Td
(journal )Tj
0.227 0.223 0.227 scn
0.05 Tc 14.2769 0 0 11.8 507.96 367.21 Tm
(of )Tj
-0.0069 Tc 11.8 0 0 11.8 524.98 367.21 Tm
(the )Tj
0.0153 Tc -32.678 -1.16 Td
(American )Tj
0.169 0.161 0.165 scn
0.0059 Tc 4.254 0 Td
(Society )Tj
0.05 Tc 14.5744 0 0 11.8 227.16 353.52 Tm
(of )Tj
0.0023 Tc 11.8 0 0 11.8 240 353.52 Tm
(Gene )Tj
-0.0003 Tc 2.42 0 Td
(Therapy)Tj
0.369 0.372 0.372 scn
0 Tc 3.4 0 Td
(, )Tj
0.227 0.223 0.227 scn
-0.0098 Tc 0.481 0 Td
(2013. )Tj
0.169 0.161 0.165 scn
/T1_0 1 Tf
-0.035 Tc 11.7391 0 0 12.2 111.87 320.17 Tm
(85. )Tj
-0.0072 Tc 12.2 0 0 12.2 140.18 320.17 Tm
(Schaller)Tj
0.29 0.286 0.29 scn
0 Tc 3.229 0 Td
(, )Tj
0.169 0.161 0.165 scn
0.675 0 Td
(T)Tj
0.29 0.286 0.29 scn
-0.035 Tc 11.3638 0 0 12.2 195.6 320.17 Tm
(., )Tj
0.169 0.161 0.165 scn
0.0079 Tc 12.2 0 0 12.2 206.51 320.17 Tm
(et )Tj
-0.0227 Tc 1.161 0 Td
(al., )Tj
0.05 Tc 12.2989 0 0 12.2 240.9 320.17 Tm
(HIV-l )Tj
0.0126 Tc 12.2 0 0 12.2 279.24 320.17 Tm
(capsid-cyclophilin )Tj
0.0286 Tc 8.028 0 Td
(interactions )Tj
0.0282 Tc 5.467 0 Td
(determine )Tj
0.0287 Tc 4.71 0 Td
(nuclear )Tj
0.0488 Tc -29.633 -1.142 Td
(import )Tj
0.0272 Tc 3.63 0 Td
(pathway, )Tj
0.0312 Tc 4.554 0 Td
(integration )Tj
0.0336 Tc 5.396 0 Td
(targeting )Tj
0.0414 Tc 4.575 0 Td
(and )Tj
0.0216 Tc 2.311 0 Td
(replication )Tj
-0.015 Tc 5.263 0 Td
(efficiency. )Tj
/T1_1 1 Tf
0.0203 Tc 11.8 0 0 11.8 513.45 306.24 Tm
(PLoS )Tj
0.0222 Tc -31.764 -1.179 Td
(pathogens)Tj
0.29 0.286 0.29 scn
0 Tc 4.342 0 Td
(, )Tj
0.227 0.223 0.227 scn
/T1_0 1 Tf
-0.0266 Tc 12.2 0 0 12.2 195.29 292.33 Tm
(2011. )Tj
0.169 0.161 0.165 scn
-0.0194 Tc 2.454 0 Td
(7\(12\): )Tj
-0.035 Tc 11.8981 0 0 12.2 257.3 292.33 Tm
(p. )Tj
-0.0126 Tc 12.2 0 0 12.2 269.63 292.33 Tm
(e1002439. )Tj
ET
q
/CS0 cs 0.159 0.159 0.159 scn
433.9199982 0.27771 -0.4349976 679.6799927 112.0261993 83.8952637 cm
/Im0 Do
Q
endstream
endobj
1558 0 obj
<>/Filter/JBIG2Decode/Height 2832/ImageMask true/Length 3018/Subtype/Image/Width 1808>>stream
0 @ D,"b&wrG58j5(wFFR[HuSg/bK"esv54YddM42{iٝC2S2X1~3ڞY7md
fnф1%ReP,bX5l|ɮ2bI>ͭX)h[`fUD],痪H}kx7XӨA{/ME@;*""NbǼYWilЮzit!Yca??0s'rJT_JN!6K` u-^Jg*d٣6~dIB)UYmlp\dVeUdI~HQ؈~]g캌r@oV:`M'r4Lnu/Pdƌs#lDھcҒѻnHΙOgrmQ:YM5Jlcac",~)u?7vi1ƷLa ݏQ/@5Zz4`۳ƉCSkk)CSFyc\:/3DFsqt;LwV~N
h